The role of Vascular Surgery and wound care treatment

Slides:



Advertisements
Similar presentations
Innovations in Coordinating Care In Disease Management.
Advertisements

Health care professionals have an important role to play in shifting institutional practices to support health by not only educating our patients and modeling.
IN THE NEXT FEW SLIDES YOU WILL SEE THE MIRACLE OF SURGICAL OFF-LOADING.
Classification Vascular → arterial → Lymphatic → Venous Infection → Chronic Osteomyelitis TB,Syphilis Systemic DM, Sickle cell anemia Neoplastic Sq.
1 Dr. Daniel Moore Medical Director Tammy Wolbert Program Director Vicky Hartsell Clinical Nurse Manager.
For Old or Young Dialysis Patients, AV Fistulas Remain Pure Gold Andrew R. Forauer, MD Michael Bazylewicz, BS Kristine A. Pattin, BS Interventional Radiology.
Why we need to change. What is Healthier Together? A look at the way health services are delivered Looking at services provided in hospitals Looking at.
Ulcerations Due to Peripheral Vascular Disease
Presented by Michelle Sitto. The term peripheral vascular disease is commonly used to refer to peripheral artery disease (PAD), meaning narrowing or occlusion.
Leg Ulcers By: Chris Copp. Description Shallow sore on your leg that won’t heal. Starting with a break of the skin, the wound turns into an ulcer when.
Calciphylaxis Induced Ulcerations. John M. Lavelle, 1 DO; Paul Liguori MD 2 1. Boston University Medical Center, Rehabilitation Department 2. Whittier.
REGISTERED NURSE (RN) Chelsea Gosey & Sheweat Kubrom 1 st period Computer technology.
Chronic Disease Management (CDM) The new world of care planning Dr Alison Sands MBBS FRACGP North East Valley Division of General Practice 14 June 2005.
CHRONIC WOUND TREATMENT. WHAT IS A WOUND AND HOW DOES OUR BODY REACT TO IT???????
Study on surgical site infection
Rashad MAHMUDOV Central Hospital of Oilworkers, Baku-Azerbaijan
The diabetes foot team Ullevål Oslo University Hospital.
Gabriel Herscu, M.D. Washington Township Medical Foundation.
Personal Health Information Management - PHIM. A relevant example for information sharing  CaringBridge.org --
Wound Care Dr. Curtis Pedersen D.P.M.. What is Wound Care ?
Improved performance of the Diabetes LDL control measure Dr Stuart V Demirs MD.
Boom! Bang! The doctors were running out of the hospital. A man shouted,” How can you leave these dying people? Look outside!”
ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute of Ophthalmology ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute.
Normal Coronary Artery Images: Coronary artery: Microscopic image of a cross section of a coronary artery:
Health & Wellness A Journey Towards Optimal Health.
MENU ΣΤΕΦΑΝΙΑΙΑ ΝΟΣΟΣ ΣΕ ΔΙΑΒΗΤΙΚΟΥΣ ΚΑΙ ΗΛΙΚΙΩΜΕΝΟΥΣ.
Heart Failure Clinic Facility: James A Haley VAMC, Tampa FL Contact Person: Jeannette McCain, MA, ARNP-C
WHO SHOULD TREAT THE DIABETIC FOOT? Mohammed Y Al-Naami, FRCSC.
By: Jess Turley 4 th hour.  A leg ulcer is a wound or open sore, that will not heal unless you take the correction actions for treatment.
Reviewing Vascular Services Tuesday 4 th June 2013.
Accountable Care Organizations ACO’s Dr. Frank Mazzeo Jr. President/Chief Executive Officer Family Health Centers of Southwest Florida, Inc.
Diabetes: Challenges in the diagnosis and care of patients in the community Dr Oudone Family Medicine Specialist CME October 15-17, 2012 Pakse.
Erica Duffy Cardiology Patients  Medically supervised program  Educational Program  Improves health of those with heart disease and other cardiovascular.
Show Me The Money Chris Cebollero, Chief. Show me the money CHAP Program - ER - EMS - Super Users Patient Treat at Home PCP Dr. Chris Perry Health Resource.
Diabetic Foot. DM largest cause of neuropathy. Foot ulcerations is most common cause of hospital admissions for Diabetics. Expensive to treat, may lead.
The Current Role of Operative Venous Thrombectomy in Deep Vein Thrombosis Anthony J. Comerota Seminars in Vascular Surgery Volume 25, Issue 1, Pages 2-12.
Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Quality of Care of and Outcomes for African Americans.
Its role in CT at Sheffield Teaching Hospitals. Elizabeth Cadman CT Radiographer.
The angiosome theory to guide revascularization for CLI
RISK FACTORS FOR WOUND DEHISCENCE AFTER LAPAROTOMY
Complex Leg Wound Service - Preventing Leg Ulcers
CHARACTERISTICS AND OUTCOME OF MAJOR LOWER LIMB AMPUTATIONS IN A TERTIARY CARE HOSPITAL Nishanthan A A, Sarangan S, Kalaventhan P, Prasath S, Gooneratne.
Clinical evaluation of recombinant human platelet – derived growth factor for the treatment of lower extremity diabetic ulcers  David L. Steed, MD, the.
ANYONE CAN REGISTER: Anyone, regardless of age or medical condition can register as a donor. Patients with diabetes, hepatitis and other chronic conditions.
Female patient I. 52 years old trophic ulcer of the left lower leg associated with chronic venous insufficiency, duration of the disease is more than 2,5.
Nat. Rev. Cardiol. doi: /nrcardio
© Topadur Pharma AG | Dezember 2017
Maria Spicer Nutrition, Food and Exercise Sciences
Teams Home Medical Home Community Hospital.
ANYONE CAN REGISTER: Anyone, regardless of age or medical condition can register as a donor. Patients with diabetes, hepatitis and other chronic conditions.
ANYONE CAN REGISTER: Anyone, regardless of age or medical condition can register as a donor. Patients with diabetes, hepatitis and other chronic conditions.
Prior authorization and patient cost-sharing are least likely to be seen as effective in reducing unnecessary care. “How effective do you think each of.
ANYONE CAN REGISTER: Anyone, regardless of age or medical condition can register as a donor. Patients with diabetes, hepatitis and other chronic conditions.
Novo Nordisk Taiwan Novo Nordisk Japan
“ ” Problem: Following a lengthy hospital stay, better control
Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: A randomized clinical trial  Eliot N. Mostow,
Louis L. Nguyen, MD, MBA, MPH  Journal of Vascular Surgery 
Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)  William R. Hiatt,
ANYONE CAN REGISTER: Anyone, regardless of age or medical condition can register as a donor. Patients with diabetes, hepatitis and other chronic conditions.
Kaplan–Meier estimates of the incidence of first heart failure hospitalization during follow-up according to the statin category among patients with type.
Aligning Forces For Quality (AF4Q)
2008 Survey Profile of Sicker Adults with Any Chronic Condition
Vascular disease, matrix abnormalities, and neuropathy: Implications for limb salvage in diabetes mellitus  Frank W. LoGerfo, M.D.  Journal of Vascular.
Vascular Surgery Michael Ricci, MD.
Limb Preservation Center:The New Frontier
Emily Spangler, Robert W. Chang, Philip P. Goodney 
Rüttermann, M; Maier-Hasselmann, A; Nink-Grebe, B; Burckhardt, M
The financial burden of surgical and endovascular treatment of diabetic foot wounds  Maximilian O. Joret, Anastasia Dean, MBBS, Colin Cao, PGDipPH, Joanna.
Age-standardized* prevalence and number of cases of diagnosed diabetes among individuals aged 1 year and older, Canada, 1998/99 to 2008/09. *Age-standardized.
Presentation transcript:

The role of Vascular Surgery and wound care treatment Dr. W. Amann Division of General- and Vascular Surgery LKH Villach, Austria XV. Educational seminar for doctors; Nov. 11, 2011 University Medical Center ( UMC ), Ljubljana

Chronic wound and vascular disease majority of patients in vascular medical units majority of hospital stay days cost intensive

Etiology of chronic wounds ( crural ulcers ) combined venous and arterial 70 % arterial ( atherosclerosis ) 20 % diabetic 5 % traumatic 3-4 % vasculitis 1 % neoplastic <1 %

Management of chronic wounds Diagnosis of vascular disease Causal treatment Local treatment

Chronic critical ischemia Stage I Asymptomatic, decreased pulses, ABI < 0.9 Stage II Intermittent claudication Stage III Daily rest pain Stage IV Focal tissue necrosis Fontaine stage III and IV prognosis Without therapy in 6 - 12 months: - 90 % major amputation With therapy in 12 months: - 25 % dead - 25 % major amputation - 50% alive, with limb salvage SECD, Eur J Vasc Endovasc Surg (1992)

Diagnostic algorithm for PAOD 1. Clinical examination 2. Pulse status 3. Ankle brachial index 4. Acral oscillography 5. Treadmill 6. Tcpo2 7. Duplex - ultrasound 8. Angiography Weitz JI et al. Circulation 1996;94:3026–3049

Becken-Bein-AngioCT

Causal treatment of vascular disease Desobliteration - Interventional ( Angioplasty ) - Surgical ( bypass surgery ) Medical vasoactive treatment - Prostanoids Combination Lumbal or thoracal sympathectomy Last option : SCS – spinal cord stimulation

Local treatment – mandatory factors Debridement ( surgical, autolytic, biological ) Moisture Wound temperature Prevent and/or treat local infection Exudate management Pain reduction Easy handling ( outpatient ) Cost effective

TIME - principles of wound bed preparation Tissue revascularization removal of non-viable or deficient tissue Infection control of infection or inflammation local antiseptic systemic antibiotics Moisture Exsudate management Edge of wound excavation hyperceratosis maceration epitheliasation

Case 1 16

Case 1 17

Case 2 18

Case 2 19

Case 2 20

Case 2 21

Case 2

Local wound therapy - dressings A lot of different dressings available A lot of confusion which one to take according to wound situation Costs ? Low evidence of what is the best

Povidone iodine infected wound easy to handle cheap potential cytotoxic Iodine allergic patients Needs secondary dressing

Alginates with/without silver Infected wounds Keeps wound moist Improves granulation good for excavates wounds Secondary dressing necessary Higher costs than iodine

Hydrogel Improves autolysis Keeps wound moist Improves granulation Secondary dressing necessary

Hydrocolloid minor exsudating wounds Keeps wound moist Improves granulation

Foams – polyurethane Moderate exsudating wound Keeps wound moist sometimes adheres to wound bed painful dressing change alterates wound bed

Superabsorber highly exsudating wounds avoids maceration primary and secondary dressing

VAC – vaccuum assisted closure large excavated wounds Good exsudate control improves granulation expensive difficult for outpatient

Summary conventional wound dressings Dressings have different characteristics Use of many different dressings in each phase of wound healing process is possible Need for high expertise to choose the best one in a certain situation Need for different combinations increases costs

PolyMem® Multifunctional dressings These multifunctional dressings promote: Gentle autolytic debridement Rapid debriding and wound healing results Reduction of pain and inflammation around the wound Non-adherence of dressings to the wound bed Quick, simple and pain-free dressing changes Might look and feel like foam dressings but due their composition they have an entirely different mode of action.

PolyMem® Multifunctional dressings All PolyMem dressings have the same core technology Hydrophilic Polyurethane (carrier) Wound cleanser - F-68 Surfactant Moisturizer – Glycerin Superabsorbent ( Copolymer ) absorbs fluids 10 ( Polymem ) to 16 fold ( Polymax ) of own weight Semi-permeable backing film ( not on cavity products) Application of PolyMem on wound, wound fluid is immediately absorbed into the dressing. Wound fluid absorbed into the dressing making it swell and fill the wound contours. Release of wound-cleanser and glycerine onto the wound bed. Surfactant and glycerine stimulate autolytic debridement. Exudate retained in the dressing due to superabsorbents.

PolyMem ® Silver ™ All the advantages of PolyMem dressings, plus the antimicrobial benefits of silver! In vitro testing demonstrates kill of at least 99.9% of all bacteria and fungi populations* Nano-crystalline silver particles are equally distributed throughout and bound into the membrane. Unlike other silver dressings - Non cytotoxic! No skin staining *Organisms tested – Klebsiella pneumoniae, Staphylococcus aureus, Pseudominas aeruginosa, Enterococcus faecalis, Staphylococcus aureus, Candid albicans

Example of effect after 24 hours 24/7 Example of effect after 24 hours Stagnating (4 months) wound on tibia after trauma. PolyMem has reduced the hypergranulation, odour and pain in only 24 hours. Note the clean wound surface and absence of the slimey film and slough that had previously covered the wound. 25/7 No need for additional cleansing!

How does PolyMem reduce pain? Inhibits the actions of the pain-sensing nerve endings under the dressings*. (“nociceptors”) These same nerves, when activated, create the series of events that result in; - bruising - swelling - edema - pain. Evidence suggests that the dressing might absorb sodium ions, by capillary action, from the skin and from the subcutaneous tissues. If this is true, then this local decrease in sodium ions would result in reduced nociceptor nerve conduction, which could account for the observed pain relief. Inflammation

An incisional study on a rodent model The coming slide demonstrates how PolyMem reduces the spread of inflammation (and pain which is linked to inflammation) in the tissue surrounding the trauma (in this case, inscisions/cuts) The inscisions on the animals were either: - left uncovered - covered with gauze (earlier study showed same result with gauze and a placebo foam) - covered with PolyMem Following slide show histological photos of the inflammatory reaction of surrounding tissue. Note that there is no reduction in the robust localized inflammatory response required for healing the injury!20 Suppression of the spread of the inflammation and swelling cascade into the surrounding, uninjured tissues helps accelerate the healing process. 16,20 Photos courtesy of Dr. Alvin J. Beitz, University of Minnesota

An incisional study on a rodent model The vertical lines measure the extent of the inflammation, which is dramatically more localized with Polymem®. Note that there is no reduction in the robust localized inflammatory response required for healing the injury!20 Suppression of the spread of the inflammation and swelling cascade into the surrounding, uninjured tissues helps accelerate the healing process. 16,20 Photos courtesy of Dr. Alvin J. Beitz, University of Minnesota

Blunt trauma animal model Uniform blunt trauma to both legs on 14 anesthetized animals PolyMem® dressing plus a compression wrap applied to one leg Only the compression wrap was applied to the other leg Two independent observers evaluated swelling (0 – 4 scale) PMD + wrap wrap PMD+wrap wrap Data courtesy of Dr. Alan R. Kahn, University of Minnesota

Charcot foot treated with PolyMem® 4,5 months to closure with PolyMem Silver WIC + PolyMem (without silver). The wound was NOT debrided or cleansed in-between dressing changes. Poster presented at EWMA 2008

Heel ulcer 1. treated with PolyMem® 3 months to closure with PolyMem Silver WIC + PolyMem. The wound was NOT debrided or cleansed in-between dressing changes. Poster presented at EWMA 2008

Heel ulcer 2. treated with PolyMem® 8 months to closure with PolyMem + PolyMem WIC. The wound was NOT debrided or cleansed in-between dressing changes. Poster presented at EPUAP 2009

PolyMem® Wic Silver Rope Main indication is tunneling wounds/fistulas Reinforced with a surgical mesh (top and bottom) Can be cut in half lengthwise (use slits as guide) Absorbs up to 6x its own weight (will swell up to 1/3) One piece removal.

PolyMem® Wic Silver Rope

Local treatment – summary Optimum: one product for all options Monotherapy Factors for cost effectiveness price nursing time need for hospital stay need for additional treatment ( pain, cleansing etc ) storage costs healing time First line local treatment